Literature DB >> 22166334

Management of pelvic organ prolapse.

Faisal Ahmed1, Tiffany Sotelo.   

Abstract

Symptomatic pelvic organ prolapse can afflict up to 10% of women. Urinary incontinence, voiding dysfunction or difficulty possibly related to bladder outlet obstruction are common symptoms. Infrequently hydronephrosis or defecatory dysfunction can be seen. The management of pelvic organ prolapse (POP) should start with adequate assessment of all pelvic floor complaints. If a patient is not symptomatic, surgical intervention is usually not indicated. While the use of a variety of graft materials are available today including porcine, dermal and synthetic grafts, that are used in some surgical approaches to pelvic organ prolapse, other more conservative approaches may prove beneficial to many patients. This article describes our approach to the patient with pelvic organ prolapse.

Entities:  

Mesh:

Year:  2011        PMID: 22166334

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  2 in total

1.  MicroRNA-29 facilitates transplantation of bone marrow-derived mesenchymal stem cells to alleviate pelvic floor dysfunction by repressing elastin.

Authors:  Minfei Jin; Yuelin Wu; Jun Wang; Weiping Ye; Lei Wang; Peipei Yin; Wei Liu; Chenhao Pan; Xiaolin Hua
Journal:  Stem Cell Res Ther       Date:  2016-11-17       Impact factor: 6.832

2.  Transplantation of bone marrow-derived mesenchymal stem cells expressing elastin alleviates pelvic floor dysfunction.

Authors:  Minfei Jin; Ying Chen; Yun Zhou; Yan Mei; Wei Liu; Chenhao Pan; Xiaolin Hua
Journal:  Stem Cell Res Ther       Date:  2016-04-05       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.